Evidence map›Paper›PMID 21917715›Full record

ArticleScience signaling2011

Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling.

Jamie R Schoenborn, Ying Xim Tan, Chao Zhang, Kevan M Shokat, Arthur Weiss

Abstract read
In one paragraph

Article in Science signaling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Article
  8. Mathematical models of TCR initial triggering.Frontiers in immunology · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jamie R SchoenbornRosalind Russell Medical Research Center for Arthritis, Division of Rheumatology, Department of Medicine, University of California, San Francisco, CA 94143, USA.
Ying Xim Tan
Chao Zhang
Kevan M Shokat
Arthur Weiss
Howard Hughes Medical Institute · USUniversity of California, San Francisco · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Leigh Clarke · 1999 to 2026
$209.7M
Understand the metabolic fitness of naïve T cellsP01AI091580 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARTHUR WEISS · 2011 to 2026
$31.1M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA082103NIAID NIH HHS P01 AI0591580NIAID NIH HHS P01 AI091580
6 · The paper itself

Abstract

The Src family kinase Lck is crucial for the initiation of TCR signaling. The activity of Lck is tightly controlled to prevent erroneous immune activation, yet it enables rapid cellular responses over a range of sensitivities to antigens. Here, in experiments with an analog-sensitive variant of the tyrosine kinase Csk, we report that Lck in T cells is dynamically controlled by an equilibrium between Csk and the tyrosine phosphatase CD45. By rapidly inhibiting Csk, we showed that changes in this equilibrium were sufficient to activate canonical TCR signaling pathways independently of ligand binding to the TCR. The activated signaling pathways showed sustained and enhanced phosphorylation compared to that in TCR-stimulated cells, revealing a feedback circuit that was sensitive to the basal signaling machinery. We identified the inhibitory adaptor molecule Dok-1 (downstream of kinase 1) as a candidate that may respond to alterations in basal signaling activity. Our results also suggest a role for Csk in the termination or dampening of TCR signals.

Indexed as

AnimalsCSK Tyrosine-Protein KinaseDNA-Binding ProteinsHumansJurkat CellsLeukocyte Common AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)MicePhosphoproteinsPhosphorylationProtein-Tyrosine KinasesReceptors, Antigen, T-CellRNA-Binding ProteinsSignal Transductionsrc-Family KinasesCSK protein, humanCSK Tyrosine-Protein KinaseDNA-Binding ProteinsDOK1 protein, humanDok1 protein, mouseLeukocyte Common AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)PhosphoproteinsProtein-Tyrosine KinasesPTPRC protein, humanPtprc protein, mouseReceptors, Antigen, T-CellRNA-Binding Proteinssrc-Family Kinases

Identifiers

PMID21917715
PMCPMC4080844
OpenAlexW2104789727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.